Literature DB >> 10051379

Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation.

B Anuradha1, P Varalakshmi.   

Abstract

Experimental neurotoxicity in rat models was induced by an intramuscular injection of mercuric chloride. dl-alpha-lipoic acid was administered as an antidote in three protocols of experimental design. Two protocols of short-term exposure of mercury was designed, one with prophylactic therapy and the other with curative therapy of lipoic acid. The third protocol was with prophylactic therapy of lipoic acid on long-term exposure of mercury. Enhanced lipid peroxidation, depleted non-enzymic and perturbed enzymic antioxidant status were observed in cerebral cortex, cerebellum and sciatic nerves of the toxic groups. The ameliorating effect of lipoic acid and its therapeutic efficacy during various modes of therapy, on the antioxidant status was established in the nervous tissues. Copyright 1999 The Italian Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051379     DOI: 10.1006/phrs.1998.0408

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  3 in total

Review 1.  Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.

Authors:  Kate Petersen Shay; Régis F Moreau; Eric J Smith; Anthony R Smith; Tory M Hagen
Journal:  Biochim Biophys Acta       Date:  2009-08-04

2.  Age and gender dependent bioavailability of R- and R,S-α-lipoic acid: a pilot study.

Authors:  Dove J Keith; Judy A Butler; Brett Bemer; Brian Dixon; Shawn Johnson; Mary Garrard; Daniel L Sudakin; J Mark Christensen; Cliff Pereira; Tory M Hagen
Journal:  Pharmacol Res       Date:  2012-05-16       Impact factor: 7.658

3.  Chronic treatment of (R)-α-lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats.

Authors:  Hardik Ghelani; Valentina Razmovski-Naumovski; Srinivas Nammi
Journal:  Pharmacol Res Perspect       Date:  2017-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.